Metropolis Healthcare unveils Key Findings from Molecular Genomics Study in honour of Lung Cancer Awareness Month
NewsVoir Mumbai Maharashtra [India]2 Lung cancer remains one of the most prevalent and deadly cancers globally with approximately 22 million new cases diagnosed annually contributing to 18 of all canc ...
On 2 year ‘cancersersary,’ WTOP’s Neal Augenstein reflects on living with lung cancer
Today marks two years since WTOP’s Neal Augenstein was diagnosed with stage 4 lung cancer. He reflects on where he’s been in his journey, and what comes next.
Akeso's Penpulimab Combination Therapy for First-line Treatment of Hepatocellular Carcinoma Accepted by NMPA
Penpulimab in combination therapy for the first-line treatment of metastatic NPC, has had its marketing application accepted by the NMPA and the FDA. Additionally, the marketing application for its ...
Too Old to Operate6h
Adjuvant durvalumab therapy improves survival in limited-stage small cell lung cancer
In this randomized controlled trial, adjuvant therapy with durvalumab led to improved overall and progression-free survival ...
Targeted Oncology16h
Future Treatment Landscape for EGFR-mutated Non-Small Cell Lung Cancer
Panelist discusses how the future treatment landscape for EGFR-mutant advanced non–small cell lung cancer is evolving to address current unmet needs and offers clinical pearls to community oncologists ...